Stephen Taub Ventyx’s RX for Going Public Third Point, Citadel, and other hedge funds are gearing up for this biopharma IPO less than a month after investing in the company’s latest financing round. Stephen Taub September 30, 2021 Michael Nagle/Bloomberg